Detalles de la búsqueda
1.
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives.
Clin Microbiol Rev
; 37(2): e0015222, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38687039
2.
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
J Infect Dis
; 226(3): 510-520, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134995
3.
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
J Infect Dis
; 223(3): 370-380, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32604408
4.
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
J Antimicrob Chemother
; 73(5): 1138-1151, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360989
5.
Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trial.
Sci Rep
; 14(1): 13499, 2024 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38866888
6.
Single-nucleotide polymorphisms in ABC drug transporters alter expression and circulating tenofovir in healthy South African women exposed to pre-exposure prophylaxis.
Pharmacogenomics
; 24(11): 599-613, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503696
7.
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial.
BMJ Open
; 13(8): e076843, 2023 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640457
8.
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial.
Lancet HIV
; 10(4): e230-e243, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37001964
9.
Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.
Front Immunol
; 13: 1055042, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36561760
10.
Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making.
J Clin Tuberc Other Mycobact Dis
; 20: 100176, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32793816
11.
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial.
BMJ Open
; 10(11): e042247, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33243815
12.
Precision medicine in resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
J Infect
; 78(4): 261-268, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849440
13.
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial.
BMJ Open
; 9(7): e030283, 2019 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31272988
14.
Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications.
Tuberculosis (Edinb)
; 107: 137-143, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29050762
15.
Failure of BACTEC™ MGIT 960™ to detect Mycobacterium tuberculosis complex within a 42-day incubation period.
Afr J Lab Med
; 6(1): 537, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28879150
16.
The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus.
IDCases
; 2(4): 116-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26793475
17.
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
PLoS One
; 8(11): e77712, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24223122
18.
Antibiotic stewardship for drug resistant tuberculosis.
Expert Opin Pharmacother
; 17(15): 1981-3, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550243
Resultados
1 -
18
de 18
1
Próxima >
>>